Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
99.5M
-
Shares change
-
-2.21M
-
Total reported value, excl. options
-
$455M
-
Value change
-
-$9.01M
-
Put/Call ratio
-
0.64
-
Number of buys
-
56
-
Number of sells
-
-66
-
Price
-
$4.57
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2020
157 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q4 2020.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.5M shares
of 316M outstanding shares and own 31.49% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), TPG Group Holdings (SBS) Advisors, Inc. (16.2M shares), WELLINGTON MANAGEMENT GROUP LLP (13.9M shares), VANGUARD GROUP INC (11M shares), BlackRock Inc. (7.41M shares), Neuberger Berman Group LLC (3.62M shares), STATE STREET CORP (2.64M shares), GEODE CAPITAL MANAGEMENT, LLC (1.64M shares), CITADEL ADVISORS LLC (1.48M shares), and NORTHERN TRUST CORP (1.4M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.